⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

Kaiser Permanente South San Francisco Medical Center

h-index: 58
Total citations: 12,913
Total papers: 392

Homepage: https://healthy.kaiserpermanente.org/northern-california/facilities/South-San-Francisco-Medical-Center-100319

Recent papers from Kaiser Permanente South San Francisco Medical Center

Electronic Visit Use for Sexually Transmitted Infection Testing in a Large Integrated Healthcare SystemClinical Infectious Diseases · 2026
Performance of Coronary Risk Scores Among Patients With Chest Pain in the Emergency DepartmentJournal of the American College of Cardiology · 2018
Continuous Glucose Monitoring and Long-Term Glycemic and Kidney OutcomesJAMA Network Open · 2026
Impact of Geriatric Surgery Verification Program Implementation on Vulnerability Assessment Rates: A Multicenter Retrospective Cohort StudyJournal of the American College of Surgeons · 2026
Intranigral injection of alpha-synuclein pre-formed fibrils leads to BBB compromise and bilateral dopaminergic neurodegeneration in A53T alpha-synuclein transgenic miceDiscover Neuroscience · 2026
Standardized Bone Health Assessment and Treatment Among Prostate Cancer Patients on Androgen Deprivation Therapy in a Large Integrated Managed Care Delivery SystemJournal of Pharmacy Practice · 2026
Refinement of Operating Characteristics for Model‐Based TGI Metrics Decision Support to Ungate a Pivotal Trial in OncologyCPT Pharmacometrics & Systems Pharmacology · 2026
E3 Ubiquitin Ligase Mindbomb1 Is a Novel Negative Regulator of Tumor-Suppressive BMP SignalingCancer Research Communications · 2026
Mass Spectrometry in Allogeneic CAR-T Cell Manufacturing: From Cellular Starting Materials to Multi-Attribute Quality ControlCells · 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumorsCancer Immunology Research · 2026
Histological and clinical phenotypes of diabetic kidney disease: a baseline analysis of the HEROIC studyClinical Kidney Journal · 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized studyClinical Cancer Research · 2026
When to Stop: Optimizing Abdominal Aortic Aneurysm Surveillance in the ElderlyJournal of Vascular Surgery · 2026
Stromal cell subsets modulate T-cell infiltration in early breast cancerCancer Research Communications · 2026
1331-OR: Hepatic IRS1 as a Therapeutic Target in Metabolic Dysfunction–Associated Liver Disease (MASLD): AI/ML-Driven Genetic Discovery and In Vivo Therapeutic ValidationDiabetes · 2026
1268-OR: Multiplexed In Vivo Screening of Visceral Adipocytes Reveals Multiple Manifestations of Insulin Sensitivity and a Novel Target to Treat ObesityDiabetes · 2026
Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis PlatformMolecular Cancer Therapeutics · 2026
2612-P: AI/ML-Driven Genetic Discovery through In Vivo Validation of Obesity TargetsDiabetes · 2026
3062-LB: Comparison of Conditioned Taste Avoidance Profiles between GLP-1 Peptides, Amylin Peptides, and Small Molecule Amylin Receptor AgonistsDiabetes · 2026
3061-LB: Combination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPsDiabetes · 2026